Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene (Q45746813)

15 December 2017

title

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene (English)

1 reference

15 December 2017

0 references

Colmenero P

1

1 reference

15 December 2017

Liljeström P

series ordinal

2

1 reference

15 December 2017

Jondal M

series ordinal

3

1 reference

15 December 2017

publication date

1 October 1999

1 reference

15 December 2017

published in

Gene Therapy

1 reference

15 December 2017

volume

6

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

1728-1733

1 reference

15 December 2017

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Tumor immunotherapy: the tumor cell as an antigen-presenting cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Death mechanisms in cultured cells infected by Semliki Forest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T cell priming versus T cell tolerance induced by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The new vaccines: building viruses that elicit antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Accidental human vaccination with vaccinia virus expressing nucleoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

CTL Response and Protection Against P815 Tumor Challenge in Mice Immunized with DNA Expressing the Tumor-Specific Antigen P815A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Identification and characterization of the tumor-specific P1A gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum− or helper peptides in priming for skin test reactivity to a P815AB‐related peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301004

1 reference

15 December 2017

Dimensions Publication ID

1042640529

0 references

1 reference

15 December 2017